Approval · Notice of Compliance 1881 · 1999
PRINIVIL: Notice of Compliance 1881
Issued September 28, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1881
- Date
- September 28, 1999
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINIVIL | 02240934 | Cancelled Post Market |
Medicinal ingredients
- LISINOPRIL 2.5 MG per TAB